Joseph Vazzano
Fortune : 3 M $ au 30/06/2026
Fortune : 3 M $ au 30/06/2026
Joseph W.
Vazzano is currently an Independent Director at Allarity Therapeutics A and Chief Financial & Accounting Officer at Abeona Therapeutics, Inc. Formerly, Mr. Vazzano was an Independent Director at Allarity Therapeutics, Inc. from 2023 to 2025, Chief Financial Officer & Secretary at Avenue Therapeutics, Inc. from 2019 to 2022, Assistant Corporate Controller at Intercept Pharmaceuticals, Inc. from 2016 to 2017, Senior Auditor at KPMG LLP, and Assistant Controller at Pernix Therapeutics, Inc. Education includes undergraduate studies at Lehigh University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/07/2026 | 492 079 ( 0,86 % ) | 3 M $ | 30/06/2026 | |
| 22/01/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur Financier/CFO | 14/03/2022 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Develops cancer medications | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/06/2025 |
| AVENUE THERAPEUTICS, INC. | Directeur Financier/CFO | 07/01/2022 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2017 |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | - |
Pernix Therapeutics, Inc.
Pernix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pernix Therapeutics, Inc.
Pernix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
Avenue Therapeutics, Inc.
Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Develops cancer medications | Health Technology |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national